Miltenyi Biotec (Germany) – www.miltenyibiotec.com
SCIDNET Principal Investigator: Ian Johnston (IanJ@miltenyibiotec.de)
Since its foundation in 1989 Miltenyi Biotec has become one of Germany’s most successful biotechnology companies with currently more than 1.500 employees worldwide. Miltenyi’s multidisciplinary R&D department, consisting of 350 scientists, technicians and engineers, is constantly developing novel reagents and instruments for use in immunology, cell biology and molecular biology. Magnetic Cell Sorting Technology (MACS®) from Miltenyi has become an established standard method in biomedical research areas like cancer research, hematology, stem cell biology or neurosciences, and furthermore in novel clinical approaches such as cellular immunotherapy, transplantation or regenerative medicine. With MACS Technology, virtually any cell type can be isolated from human and animal cells up to plant cells and bacteria. Miltenyi Biotec develops, produces and markets more than 15.000 state-of-the-art products and services.